NEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...

Preliminary Data Shows Platform Generated Over $1.36 Million in Just 14 Days; Daily Revenue Velocity Accelerating Rapidly ...

In the third quarter, our revenue were $1 billion, driven by sales of our fully approved vaccines, Spikevax, mNEXSPIKE, ...

The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...

LIB Therapeutics Inc. (LIB), a privately held biopharmaceutical company with a singular focus on helping high-risk patients achieve their cholesterol goals, today announced the U.S. Food and Drug ...

NEW YORK, NY / ACCESS Newswire / December 15, 2025 / As the market has paid increasing attention to, and begun revaluing, SMX's potential across plastics, gold, rare earths, and hardware ...

GSK said on Friday a panel ‍of the European Medicines Agency had backed the use of its ‌respiratory syncytial ‌virus (RSV) ...

HERNDON, VA / ACCESS Newswire / December 15, 2025 / Out of 28 bidders, the U.S. Department of the Treasury has awarded ThinkTrends a $26 million prime contract under a multiple-award IDIQ. Through ...

An Austrian appeals court has rejected a request to extradite Ukrainian businessman Dmytro Firtash to the United States. The ...

France is creating a last-minute hurdle for a major trade deal between the European Union and the Mercosur bloc. European ...

With an expected historic refund season on the horizon, new law brings major shifts to credits, deductions, and planning for families and small businesses. HURST, TX / ACCESS Newswire / December 15, ...

In a new study, adults 45 and up who got this seasonal virus had a higher risk of major heart issues, especially in the first ...